Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-12-05 Sale | 2023-12-06 8:24 pm | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Sr. VP & CMO | 534 | $9.63 | $5,142 | 26,466 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-12 Tax Withholding | 2024-02-14 8:15 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 755 | $12.41 | 28,287 (Direct) | View |
| 2024-02-12 Option Award | 2024-02-14 8:15 pm | N/A N/A | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 2,576 | $0 | 28,287 (Direct) | View |
| 2023-11-22 Option Award | 2023-11-22 5:10 pm | N/A 2033-11-22 | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Sr. VP & CMO | 86,000 | $0 | 86,000 (Direct) | View |
| 2022-11-23 Option Award | 2022-11-28 6:28 pm | N/A 2032-11-23 | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 22,000 | $0 | 42,000 (Direct) | View |
| 2022-08-08 Option Award | 2022-08-11 4:32 pm | N/A 2032-08-08 | ENANTA PHARMACEUTICALS INC | ENTA | Rottinghaus Scott T. Chief Medical Officer | 95,000 | $0 | 95,000 (Direct) | View |